Multiple Sclerosis market The leading Multiple Sclerosis Companies, such as Roche, Sanofi, Novartis, and AB Science, among others, are progressing their assets through various clinical trial phases, driving innovation in
Multiple Sclerosis market is projected to grow at a CAGR of 3.80% by 2034 in 7MM
Hyperparathyroidism market PARSABIV and RAYALDEE are approved in the US for secondary hyperparathyroidism, whereas ORKEDIA and UPASITA are approved in Japan for secondary hyperparathyroidism, only PARSABIV is the only drug
Global KRAS Inhibitors Market Among the 7MM, the United States captured the highest KRAS inhibitors market size in 2024, accounting for nearly 70% of the total KRAS inhibitors market share.
HER2-low cancers market Recent FDA approval of ENHERTU in HER2-low/ultralow breast cancer has validated HER2-low as a key therapeutic target. The shift toward earlier-line treatment settings is expected to drive
DelveInsight’s “Major Depressive Disorder Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the
B-Cell Chronic Lymphocytic Leukemia Market Key B-Cell Chronic Lymphocytic Leukemia Companies are AstraZeneca, Bristol-Myers Squibb, Merck, Ascentage Pharma, BeOne Medicines,
Metal Fabrication Equipment Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the Metal
Polymer Binder Market Mordor Intelligence’s new study on the “Polymer Binder Market” presents a thorough evaluation of the market’s trajectory,
Biostimulants Market Size & Trends | Mordor Intelligence The global biostimulants market is poised for strong expansion, growing from USD
The Building Management System Market is projected to grow from USD 41.87 billion in 2025 to USD 116.73 billion by
